• About Us
    • Our Company
    • Management Team
    • Board of Directors
    • Clinical Advisory Board
  • Product Candidates
  • Recent News
    • Press Releases
    • Research + Whitepapers
    • News
  • Contact Us
The AI Paradigm Shift: How Cutting-Edge Tech is Fast-Tracking the Future of Medicine

The AI Paradigm Shift: How Cutting-Edge Tech is Fast-Tracking the Future of Medicine

by Dr. Josep Bassaganya-Riera | Sep 10, 2024 | Press Release

An original version of this article appeared in the Pharmaceutical Executive. The AI revolution is shaping numerous facets of our lives. While advancements by OpenAI and Anthropic plus NVIDIA’s market performance have commanded a significant portion of media...

Recent Posts

  • NImmune Biopharma Presented New Data at ACG 2026 Supporting the Efficacy and Safety of Innovative LANCL2 Medicines Targeting a Novel Mechanism in Hard-to-Treat IBD
  • NImmune Biopharma Announces Presentations at ACG 2026 Supporting Efficacy of Oral, Once-Daily NIM-1324 LANCL2 Medicine for Hard-to-Treat IBD
  • NImmune Biopharma Announces Presentations at Digestive Disease Week 2026 Supporting a Differentiated Profile and Superior Efficacy of Oral, Once-Daily NIM-1324 for IBD
  • New Data Presented at IMMUNOLOGY2026 Shows LANCL2 Medicines in Clinical Development for IBD Can Provide Protection from Asthma
  • NImmune Biopharma to Present Novel Mechanistic, Efficacy and Translational Data on LANCL2-Targeting Therapeutics Supporting Significant Pipeline-in-a-Drug Potential at IMMUNOLOGY2026

Recent Comments

No comments to show.
  • About Us
  • Management Team
  • Board of Directors
  • Clinical Advisory Board
  • Product Candidates
  • Contact Us

Copyright © 2025 NImmune Biopharma